Antiplasmodial structure–activity relationship of 3-trifluoromethyl-2-arylcarbonylquinoxaline 1,4-di-N-oxide derivatives
- 1 January 2008
- journal article
- Published by Elsevier in Experimental Parasitology
- Vol. 118 (1), 25-31
- https://doi.org/10.1016/j.exppara.2007.05.009
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Malaria: Burden of DiseaseCurrent Molecular Medicine, 2006
- The global distribution of clinical episodes of Plasmodium falciparum malariaNature, 2005
- PEDIATRIC MORTALITY IN AFRICA: PLASMODIUM FALCIPARUM MALARIA AS A CAUSE OR RISK?The American Journal of Tropical Medicine and Hygiene, 2004
- Synthesis and anticancer activity evaluation of new 2-alkylcarbonyl and 2-benzoyl-3-trifluoromethyl-quinoxaline 1,4-di-N-oxide derivativesBioorganic & Medicinal Chemistry, 2004
- Synthesis of new arylaminoquinoxalines and their antimalarial activity in miceJournal of Pharmacy and Pharmacology, 2001
- Hypoxia-Selective Agents Derived from Quinoxaline 1,4-Di-N-oxidesJournal of Medicinal Chemistry, 1995
- Measurement of the Lactate Dehydrogenase Activity of Plasmodium falciparum as an Assessment of ParasitemiaThe American Journal of Tropical Medicine and Hygiene, 1993
- Human Malaria Parasites in Continuous CultureScience, 1976